These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20122099)

  • 21. Nanotech under scrutiny, but tighter regulation remains distant.
    Kling J
    Nat Biotechnol; 2007 Oct; 25(10):1068. PubMed ID: 17921977
    [No Abstract]   [Full Text] [Related]  

  • 22. Nanoregulation: a recent scare involving nanotech products reveals that the technology is not yet properly regulated.
    Wolinsky H
    EMBO Rep; 2006 Sep; 7(9):858-61. PubMed ID: 16953197
    [No Abstract]   [Full Text] [Related]  

  • 23. State biotechnology oversight: the juncture of technology, law, and public policy.
    Vito CC
    Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
    [No Abstract]   [Full Text] [Related]  

  • 24. Technology: Nanomaterials need flexible regulation.
    Wickson F
    Nature; 2011 Aug; 476(7360):283. PubMed ID: 21850092
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EU wrangles internally over safety of donated tissues and cells.
    Vermij P
    Nat Biotechnol; 2003 Dec; 21(12):1420. PubMed ID: 14647315
    [No Abstract]   [Full Text] [Related]  

  • 27. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
    Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
    [No Abstract]   [Full Text] [Related]  

  • 28. The US must help set international standards for nanotechnology.
    Murashov V; Howard J
    Nat Nanotechnol; 2008 Nov; 3(11):635-6. PubMed ID: 18989319
    [No Abstract]   [Full Text] [Related]  

  • 29. The continuing uncertainty of nano risks and regulations.
    Chatterjee R
    Environ Sci Technol; 2008 Nov; 42(21):7733. PubMed ID: 19031851
    [No Abstract]   [Full Text] [Related]  

  • 30. Governance strategies for living technologies: bridging the gap between stimulating and regulating technoscience.
    van Est R; Stemerding D
    Artif Life; 2013; 19(3-4):437-50. PubMed ID: 23834596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tighter nanotech regulations touted.
    Sanderson K
    Nature; 2009 Feb; 457(7230):647. PubMed ID: 19194417
    [No Abstract]   [Full Text] [Related]  

  • 32. The emergence of the nanobiotechnology industry.
    Maine E; Thomas VJ; Bliemel M; Murira A; Utterback J
    Nat Nanotechnol; 2014 Jan; 9(1):2-5. PubMed ID: 24390555
    [No Abstract]   [Full Text] [Related]  

  • 33. The politicization of science and technology: its implications for nanotechnology.
    Jotterand F
    J Law Med Ethics; 2006; 34(4):658-66. PubMed ID: 17199806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Needed: a modest proposal.
    Schmidt H
    Hastings Cent Rep; 2007; 37(6):6; author reply 10-1. PubMed ID: 18179094
    [No Abstract]   [Full Text] [Related]  

  • 35. Transnational models for regulation of nanotechnology.
    Marchant GE; Sylvester DJ
    J Law Med Ethics; 2006; 34(4):714-25. PubMed ID: 17199813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International standards for risk management in nanotechnology.
    Hatto P
    Nat Nanotechnol; 2009 Apr; 4(4):205; author reply 205-6. PubMed ID: 19350019
    [No Abstract]   [Full Text] [Related]  

  • 37. Needed: a modest proposal.
    Greenfield D
    Hastings Cent Rep; 2007; 37(6):8; author reply 9-11. PubMed ID: 18179096
    [No Abstract]   [Full Text] [Related]  

  • 38. Does REACH go too far?
    Bowman DM; van Calster G
    Nat Nanotechnol; 2007 Sep; 2(9):525-6. PubMed ID: 18654355
    [No Abstract]   [Full Text] [Related]  

  • 39. The governance of human genetics: policy discourse and constructions of public trust.
    Jones M; Salter B
    New Genet Soc; 2003 Apr; 22(1):21-41. PubMed ID: 15282897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Federal Policy toward health care technology: the case of the National Center.
    Blumenthal D
    Milbank Mem Fund Q Health Soc; 1983; 61(4):584-613. PubMed ID: 6557372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.